The collaboration marks LordsMed foray into the rapid antigen diagnostic kit segment
LordsMed has entered into an exclusive partnership with Singapore-based diagnostics kit manufacturer Sensing Self to bring COVID-19 saliva-based rapid antigen test kit to India. With a reduced turn-around time, the rapid antigen test kit will make COVID mass screening scalable.
The collaboration marks LordsMed foray into the rapid antigen diagnostic kit segment. It has plans to venture into the OEM manufacturing space in the diagnostics sector with its advanced manufacturing facility at Vasai near Mumbai which will be operational soon.
As a part of the agreement with Sensing Self, Lord’s Mark Industries will collaborate with various government agencies and authorities to offer the COVID-19 saliva-based rapid antigen kits to support large-scale mass screening for COVID at various passenger transit-points like airports apart from offices and manufacturing units. The company will also tie up with primary health centres (PHCs) in various rural areas to strengthen the COVID-19 mass-screening facility in the hinterland of the country.